These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 8013750)

  • 1. Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDM.
    Polonsky KS; Gumbiner B; Ostrega D; Griver K; Tager H; Henry RR
    Diabetes; 1994 Jul; 43(7):871-7. PubMed ID: 8013750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance.
    Reaven GM; Chen YD; Hollenbeck CB; Sheu WH; Ostrega D; Polonsky KS
    J Clin Endocrinol Metab; 1993 Jan; 76(1):44-8. PubMed ID: 8421101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of effects of weight loss by monounsaturated fatty acids in obese NIDDM patients.
    Low CC; Grossman EB; Gumbiner B
    Diabetes; 1996 May; 45(5):569-75. PubMed ID: 8621005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved beta cell function, with reduction in secretion of intact and 32/33 split proinsulin, after dietary intervention in subjects with type 2 diabetes mellitus.
    Davies MJ; Metcalfe J; Day JL; Grenfell A; Hales CN; Gray IP
    Diabet Med; 1994; 11(1):71-8. PubMed ID: 8181257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related alteration of pancreatic beta-cell function. Increased proinsulin and proinsulin-to-insulin molar ratio in elderly, but not in obese, subjects without glucose intolerance.
    Shimizu M; Kawazu S; Tomono S; Ohno T; Utsugi T; Kato N; Ishi C; Ito Y; Murata K
    Diabetes Care; 1996 Jan; 19(1):8-11. PubMed ID: 8720525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoradiometric assay of insulin, intact proinsulin and 32-33 split proinsulin and radioimmunoassay of insulin in diet-treated type 2 (non-insulin-dependent) diabetic subjects.
    Clark PM; Levy JC; Cox L; Burnett M; Turner RC; Hales CN
    Diabetologia; 1992 May; 35(5):469-74. PubMed ID: 1521730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients.
    Wing RR; Blair EH; Bononi P; Marcus MD; Watanabe R; Bergman RN
    Diabetes Care; 1994 Jan; 17(1):30-6. PubMed ID: 8112186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities of insulin pulsatility and glucose oscillations during meals in obese noninsulin-dependent diabetic patients: effects of weight reduction.
    Gumbiner B; Van Cauter E; Beltz WF; Ditzler TM; Griver K; Polonsky KS; Henry RR
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2061-8. PubMed ID: 8964829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus.
    Henry RR; Scheaffer L; Olefsky JM
    J Clin Endocrinol Metab; 1985 Nov; 61(5):917-25. PubMed ID: 4044780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a monounsaturated fatty acid-enriched hypocaloric diet on cardiovascular risk factors in obese patients with type 2 diabetes.
    Gumbiner B; Low CC; Reaven PD
    Diabetes Care; 1998 Jan; 21(1):9-15. PubMed ID: 9538963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy.
    Rachman J; Levy JC; Barrow BA; Manley SE; Turner RC
    Diabetes; 1997 Oct; 46(10):1557-62. PubMed ID: 9313749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Day-long integrated serum insulin and C-peptide profiles in patients with NIDDM. Correlation with urinary C-peptide excretion.
    Garvey WT; Olefsky JM; Rubenstein AH; Kolterman OG
    Diabetes; 1988 May; 37(5):590-9. PubMed ID: 3282946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proinsulin and insulin concentrations following intravenous glucose challenges in normal, obese, and non-insulin-dependent diabetic subjects.
    Davis SN; Piatti PM; Monti L; Brown MD; Branch W; Hales CN; Alberti KG
    Metabolism; 1993 Jan; 42(1):30-5. PubMed ID: 8446045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up of women with previous GDM. Insulin, C-peptide, and proinsulin responses to oral glucose load.
    Persson B; Hanson U; Hartling SG; Binder C
    Diabetes; 1991 Dec; 40 Suppl 2():136-41. PubMed ID: 1748243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proinsulin levels predict the development of non-insulin-dependent diabetes mellitus (NIDDM) in Japanese-American men.
    Kahn SE; Leonetti DL; Prigeon RL; Boyko EJ; Bergstom RW; Fujimoto WY
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S63-6. PubMed ID: 8894485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of weight loss on insulin secretion and in vivo insulin sensitivity in obese diabetic and non-diabetic subjects.
    Escalante-Pulido M; Escalante-Herrera A; Milke-Najar ME; Alpizar-Salazar M
    Diabetes Nutr Metab; 2003; 16(5-6):277-83. PubMed ID: 15000438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intact proinsulin, des 31,32 proinsulin, and specific insulin concentrations among nondiabetic and diabetic subjects in populations at varying risk of type 2 diabetes.
    Nagi DK; Knowler WC; Mohamed-Ali V; Bennett PH; Yudkin JS
    Diabetes Care; 1998 Jan; 21(1):127-33. PubMed ID: 9538983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM.
    Markovic TP; Jenkins AB; Campbell LV; Furler SM; Kraegen EW; Chisholm DJ
    Diabetes Care; 1998 May; 21(5):687-94. PubMed ID: 9589225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance.
    Ward WK; LaCava EC; Paquette TL; Beard JC; Wallum BJ; Porte D
    Diabetologia; 1987 Sep; 30(9):698-702. PubMed ID: 3322910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes.
    Kautzky-Willer A; Thomaseth K; Ludvik B; Nowotny P; Rabensteiner D; Waldhäusl W; Pacini G; Prager R
    Diabetes; 1997 Apr; 46(4):607-14. PubMed ID: 9075800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.